H-index: 22
Carlos Alberto Cano Gutierrez (ORCID: 0000-0001-5680-7880)
Pontificia Universidad Javeriana
Angel Alberto Garcia Peña (ORCID: 0000-0002-3606-2102)
Pontificia Universidad Javeriana
H-index: 14
Latin America-Colombia
Top articles of Angel Alberto Garcia Peña (ORCID: 0000-0002-3606-2102)
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PORTABLE SINGLE-LEAD EKG KARDIA MOBILE DEVICE IS ACCURATE FOR QTc EVALUATION OF HOSPITALIZED PATIENTS WITH SUSPECTED OF SARS-CoV-2 INFECTION (COVID-19) | MARIA MARIN Angel García Oscar Muñoz Julio Castellanos Edward Cáceres | 2024/1/30 | |
Use of portable single‐lead electrocardiogram device as an alternative for QTc monitoring in critically ill patients | Annals of Noninvasive Electrocardiology | Martin Rebolledo‐Del Toro Ana Beatriz Carvajalino‐Galeano Clarena Pinto‐Brito Oscar Mauricio Muñoz‐Velandia Ángel Alberto García‐Peña | 2024/5 |
Estudio Observacional Multizonal realizado por Médicos Clínicos sobre el Uso de Repatha® en Pacientes con Hiperlipidemia (ZERBINI): resultados colombianos | Clínica e Investigación en Arteriosclerosis | HM Roncancio JR Lugo-Peña AA García J Leal CA Hoyos | 2024 |
Adherence to treatment guidelines in Ambulatory Heart Failure Patients with Reduced Ejection Fraction in a Latin-American Country: Observational Study of the Colombian Heart … | Cardiology | Alex Rivera-Toquica Luis Eduardo Echeverría Carlos Andrés Arias-Barrera Fernán Mendoza-Beltrán Diego Hernán Hoyos-Ballesteros | 2024/2/15 |
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results | Clínica e Investigación en Arteriosclerosis | Heidy M Roncancio Julián R Lugo-Peña Ángel A García Janeth Leal Carlos A Hoyos | 2024/1/1 |
Clinical outcomes associated with the use of sacubitril/valsartan in the perioperative period of patients undergoing cardiac surgery: a systematic review | Laura Gilón Valentina Dávila Óscar Muñoz Ángel García Edward Cáceres | 2024/2/5 | |
REC: CardioClinics | Laura Gilón Valentina Dávila Óscar Munoz Ángel García Edward Cáceres | 2024 | |
Frecuencia y distribución geográfica del uso de sacubitril/valsartán en Colombia entre los años 2019 y 2020 | Revista Colombiana de Cardiología | Nancy Herrera-Leaño Julián E Barahona-Correa Oscar Muñoz-Velandia Daniel G Fernández-Ávila Ángel A García | 2024/2 |
Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study | Global Heart | Jose Patricio Lopez-Lopez Martin Rebolledo-Del Toro Daniel Martinez-Bello Ángel A Garcia-Peña Gary O’Donovan | 2024 |
Frequency and geographical distribution of the use of sacubitril/valsartan in Colombia between 2019 and 2020 | Revista Colombiana de Cardiología | Nancy Herrera-Leaño Julián E Barahona-Correa Oscar Muñoz-Velandia Daniel G Fernández-Ávila Ángel A García | 2024/2 |
Proproteína convertasa subtilisina-kexina tipo 9 (IPCSK9) y riesgo residual | RIESGO RESIDUAL | Ángel A García-Peña Luz C Zárate-Correa Claudia Monsalve-Arango | 2023 |
EE223 Impact of Inclusion of Vericiguat in the Burden of Disease of Heart Failure with Reduced Ejection Fraction (HFREF) and Worsening HF Event in Colombia | Value in Health | C López-Cabra P Lasalvia SJ Rey JS Franco-Aristizabal A Patiño | 2023/6/1 |
Análisis del programa de apoyo al paciente de evolocumab (Repatha®) para pacientes con enfermedades cardiovasculares en Colombia | Clínica e Investigación en Arteriosclerosis | Ángel Alberto García-Peña Mariana Pineda-Posada Carol Páez-Canro César Cruz Daniel Samacá-Samacá | 2023/11/1 |
Colombian Cholesterol Roadmap. National roundtable on cholesterol in Colombia. Call to action | Revista Colombiana de Cardiología | Ángel A García-Peña Luz C Zárate-Correa Rafael L Campo Jaime A Rodríguez-Plazas Dagnóvar Aristizábal | 2023/12 |
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and residual risk | Scientific Reports | Hui Wang Qian Wang Jintao Wang Chiao Guo Kyle Kleiman | 2017/10/30 |
Prevalence of cardiovascular risk factors in a historical cohort of people living with human immunodeficiency virus during a 10-year period | SAGE Open Medicine | Ángel García-Peña Jairo Aldana Juan David Botero Juan Manuel Vasquez Miguel León | 2023/4 |
Ruta de atención y manejo de la dislipidemia en el paciente con síndrome coronario agudo: brechas y recomendaciones | Revista Colombiana de Cardiología | Álvaro J Ruiz Miguel Urina-Triana Juan E Gómez-Mesa Andrés F Buitrago Gilberto A Castillo | 2023/10 |
Ruta colombiana del colesterol. Mesa redonda nacional sobre el colesterol en Colombia. Llamado a la acción | Revista Colombiana de Cardiología | Ángel A García-Peña Luz C Zárate-Correa Rafael L Campo Jaime A Rodríguez-Plazas Dagnóvar Aristizábal | 2023/12 |
Waist circumference cut-off points to identify major cardiovascular events and incident diabetes in Latin America: findings from the prospective Urban rural epidemiology study … | Frontiers in Cardiovascular Medicine | Jose P Lopez-Lopez Ana María Gonzalez Paola Lanza Daniel Martinez-Bello Diego Gomez-Arbelaez | 2023 |
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis | Martín Rebolledo Del Toro Nancy M Herrera Leano Julián E Barahona-Correa Oscar M Munoz Velandia Daniel G Fernández Ávila | 2023/3 |
Co-Authors
H-index: 19
Daniel G. Fernández-Ávila, M.D. MSc. PhD. (ORCID: 0000-0003-1490-1822)
Pontificia Universidad Javeriana
